TABLE 4.

Comparison of rep-PCR pattern, community versus hospital onset, health care-associated risk factors in past 12 months, and outcomes

PFGE cluster and rep-PCR no.	n	eGenomics spa type (Ridom)	No. (%) of patients with:
			HAHO-MRSA	HACO-MRSA	CA-MRSA	Prior hospitalization	History of invasive devices	Prior surgery	Prior MRSA	LTCF	Hemodialysis	Cure	Fatality
PFGE 100, SCCmec II
2	38	2(t002), 11(t105), 23(t548), 693(t1062)	16 (42)	19 (50)	3 (8)	19 (50)	24 (63)	14 (37)	3 (8)	16 (42)	6 (16)	19 (50)	12 (32)
15	17	2(t002), 47(t045), 233(t450)	8 (47)	9 (53)	0	17(100)	8 (47)	12 (71)	3 (18)	8 (47)	4 (24)	6 (35)	4 (24)
66	17	2(t002), 11(t105), 12(tt062), 24(t242)	7 (41)	9 (53)	1 (6)	10 (59)	7 (41)	6 (35)	1 (6)	4 (24)	1 (6)	4 (24)	8 (47)
60	13	2(t002)	6 (46)	7 (54)	0	8 (62)	5 (39)	4 (31)	1 (8)	6 (46)	3 (23)	6 (46)	1 (8)
34	9	2(t002), 11(t105), 47(t045)	4 (44)	5 (56)	0	5 (56)	4 (44)	5 (55)	1 (11)	4 (44)	4 (44)	4 (44)	0
30	9	2(t002), 268(t067)	5 (56)	4 (44)	0	3 (33)	4 (44)	3 (33)	0	4 (44)	3 (33)	3 (33)	4 (44)
29	8	2(t002), 11(t105), 1211(t837)	3 (38)	5 (63)	0	6 (75)	5 (63)	2 (25)	1 (13)	4 (50)	2 (25)	5 (63)	0
PFGE ST239, SCCmec III
6	15	3(t037)	3 (20)	12 (80)	0	13 (87)	9 (60)	4 (27)	6 (40)	6 (40)	3 (20)	8 (53)	2 (13)
53	10	3(t037)	6 (60)	4 (40)	0	7 (70)	5 (50)	4 (40)	2 (20)	1 (10)	4 (40)	1 (10)	2 (20)
PFGE 300, SCCmec IV
9	33	1(t001), 4(t051), 139(t334), 363(t024), 364(t622), 722(t1578)	11 (33)	15 (46)	7 (21)	19 (58)	12 (36)	8 (24)	5 (15)	3 (9)	4 (12)	20 (61)	1 (3)
63	20	1(t001), 46(t190), 68(t451), 245(t121), 364(t622), 664(t197)	5 (25)	13 (65)	2 (10)	10 (50)	10 (50)	3 (15)	6 (30)	5 (25)	3 (15)	15 (75)	4 (20)
13	10	1(t001), 363(t024)	2 (20)	4 (40)	4 (40)	4 (40)	2 (20)	0	0	1 (10)	2 (20)	7 (70)	1 (10)
52	9	1(t001)	2 (22)	6 (67)	1 (11)	7 (78)	4 (44)	2 (22)	1 (11)	3 (33)	2 (22)	3 (33)	3 (33)
PFGE 800, SCCmec IV
55	9	2(t002), 23(t548), 24(t242), 29(t088), 176(t688), 203(t179), 437(tt003), new(new)	5 (56)	4 (44)	0	1 (11)	3 (33)	2 (22)	1 (11)	0	0	7 (78)	2 (22)